Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | GLA | P06280 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | PARP1 | P09874 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | CASP6 | P55212 | 1/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.58 |
| ▸ | CTSV | O60911 | 1/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | CDK4 | P11802 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29423967 | 1.00 | GAA (0.67) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL29360002 | 1.00 | GAA (0.67) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL5342370 | 0.90 | PARP1 (0.58) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL6325907 | 0.89 | CDK4 (0.69) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL5335867 | 0.87 | PARP1 (0.59) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL31473178 | 0.87 | PARP1 (0.59) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL25791861 | 0.86 | PARP1 (0.55) | GAAALDH1A1KDM4EGLAHTT | |
| Carbazole SCHEMBL28862120 | 0.84 | PARP1 (0.67) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL29565567 | 0.84 | PARP1 (0.67) | GAAALDH1A1KDM4EGLAHTT | |
| SCHEMBL29483487 | 0.84 | PARP1 (0.67) | GAAALDH1A1KDM4EGLAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015033743-A1 | METHOD FOR PREPARING LABELED SUGAR CHAIN SAMPLE | 住友ベークライト株式会社 (JP) | 2015-03-12 | — | — | WO | claimed |
| US-8828732-B2 | Method of labeling sugar chain | SUMITOMO BAKELITE CO., LTD. (JP) | 2014-09-09 | — | — | US | claimed |
| EP-2685263-A1 | SUGAR CHAIN FLUORESCENT LABELING METHOD | Sumitomo Bakelite Co., Ltd. (JP) | 2014-01-15 | — | — | EP | claimed |
| EP-2282209-B1 | METHOD FOR LABELLING SUGAR CHAINS | SUMITOMO BAKELITE CO (JP) | 2012-10-03 | — | — | EP | claimed |
| US-20110089033-A1 | METHOD OF PREPARING SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD OF ANALYZING SUGAR CHAIN | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-04-21 | — | — | US | claimed |
| EP-2295962-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | Sumitomo Bakelite Co., Ltd. (JP) | 2011-03-16 | — | — | EP | claimed |
| US-20110046364-A1 | METHOD OF LABELING SUGAR CHAIN | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-02-24 | — | — | US | claimed |
| EP-2282209-A1 | METHOD FOR LABELLING SUGAR CHAINS | Sumitomo Bakelite Company Limited (JP) | 2011-02-09 | — | — | EP | claimed |
| WO-2009150834-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | 住友ベークライト株式会社 (JP) | 2009-12-17 | — | — | WO | claimed |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-02-10 | — | — | US | disclosed |
| EP-4473051-B1 | COMPOUND, RUBBER BLEND CONTAINING THE COMPOUND, VEHICLE TIRE COMPRISING THE RUBBER BLEND IN AT LEAST ONE COMPONENT, PROCESS FOR PREPARING THE COMPOUND, AND USE OF THE COMPOUND AS AN ANTI-AGING AGENT AND/OR ANTIOXIDANT | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2025-11-12 | — | — | EP | disclosed |
| EP-3896074-B1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | AIST (JP) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023164238-A1 | PROTEASE INHIBITORS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2023143677-A1 | COMPOUND, RUBBER BLEND CONTAINING THE COMPOUND, VEHICLE TIRE COMPRISING THE RUBBER BLEND IN AT LEAST ONE COMPONENT, PROCESS FOR PREPARING THE COMPOUND, AND USE OF THE COMPOUND AS AN ANTI-AGING AGENT AND/OR ANTIOXIDANT | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2023-08-03 | — | — | WO | disclosed |
| US-20050070568-A1 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2005-03-31 | — | — | US | disclosed |
| EP-1474397-A1 | THERAPEUTIC ACRIDONE AND ACRIDINE COMPOUNDS | Cancer Research Technology Limited (GB) | 2004-11-10 | — | — | EP | disclosed |
| US-20040191792-A1 | Acridone derivatives as labels for fluorescence detection of target materials | GE HEALTHCARE UK LIMITED (GB) | 2004-09-30 | — | — | US | disclosed |
| EP-1392776-A2 | ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS | Amersham Biosciences UK Limited (GB) | 2004-03-03 | — | — | EP | disclosed |
| WO-2003059885-A1 | THERAPEUTIC ACRIDONE AND ACRIDINE COMPOUNDS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2003-07-24 | — | — | WO | disclosed |
| WO-2002099424-A2 | ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS | AMERSHAM BIOSCIENCES UK LIMITED (GB) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070568-A1 | Therapeutic acridone and acridine compounds | CCNK, TERT, CCNA1 | GAA 3128/4885ALDH1A1 99/4885KDM4E 884/4885 |
| US-20110046364-A1 | METHOD OF LABELING SUGAR CHAIN | SLC2A2, FUT6, SLC2A1 | GAA 60/4885ALDH1A1 840/4885KDM4E 2891/4885 |
| US-20040191792-A1 | Acridone derivatives as labels for fluorescence detection of target materials | ACR, ARSA, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | GAA 2987/4885ALDH1A1 1640/4885KDM4E 3007/4885 |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | FUT7, FUT4, SIGLEC7 | GAA 113/4885ALDH1A1 1573/4885KDM4E 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.